Special Issue "Biomarkers for Metabolism and Cardiometabolic Diseases"
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 9044
Special Issue Editor

Interests: cardiovascular pharmacology; pharmacokinetics; cardiometabolic diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biomarkers are objective and quantitatively measurable indicators of biological or pathogenic processes and can include small molecular entities as well as large molecular weight proteins and genetic materials. Biomarkers are increasingly used in drug discovery and development, the diagnosis of diseases, managing disease progression, and practicing precision medicine. This Special Issue is devoted to the application of biomarkers for the management of cardiovascular and metabolic diseases, the development of drugs and therapeutics, and managing disease progression and prognosis. Topics covered by this Special Issue will include (though not exclusively) the identification of metabolites and/or biomarkers as targets for drugs and natural health products; the validation of targets derived from biomarkers; metabolites and/or biomarkers as therapeutics; and biomarkers for drug development, disease modeling and management, and precision medicine. We anticipate that it will be a timely topic in the fight against the worldwide COVID-19 infection, which is known to be highly impacted by metabolism and cardiovascular diseases.
Prof. Dr. Pollen K. Yeung
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- drugs
- natural health products
- metabolites
- therapeutics
- cardiometabolic diseases